SCHEMBL5179922

SCHEMBL5179922

CCN(CC)c1ccc(C=NN(CC2CO2)c2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 15/20 0.46
KMT2A Q03164 5/20 0.46
MEN1 O00255 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
MCL1 Q07820 3/20 0.46
KDM4E B2RXH2 7/20 0.44
GAA P10253 4/20 0.44
MAPT P10636 10/20 0.44
TDP1 Q9NUW8 4/20 0.43
MAPK1 P28482 3/20 0.43
ESRRG P62508 1/20 0.43
RAB9A P51151 3/20 0.42
NPC1 O15118 2/20 0.42
LMNA P02545 3/20 0.42
POLB P06746 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
HSP90AA1 P07900 1/20 0.41
HPGD P15428 3/20 0.40
GLA P06280 1/20 0.40
CYP1A2 P05177 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5858661 1.00 ALDH1A1 (0.46) ALDH1A1KMT2AMEN1SMN1; SMN2MCL1
SCHEMBL5858649 0.92 ALDH1A1 (0.53) ALDH1A1KMT2AMEN1SMN1; SMN2MCL1
SCHEMBL5858647 0.92 ALDH1A1 (0.53) ALDH1A1KMT2AMEN1SMN1; SMN2MCL1
SCHEMBL5630076 0.90 ALDH1A1 (0.47) ALDH1A1KMT2AMEN1SMN1; SMN2MCL1
SCHEMBL14254908 0.90 ALDH1A1 (0.47) ALDH1A1KMT2AMEN1SMN1; SMN2MCL1
SCHEMBL4821647 0.90 ALDH1A1 (0.47) ALDH1A1KMT2AMEN1SMN1; SMN2MCL1
SCHEMBL4821644 0.90 ALDH1A1 (0.47) ALDH1A1KMT2AMEN1SMN1; SMN2MCL1
SCHEMBL5180365 0.87 ALDH1A1 (0.61) ALDH1A1KMT2AMEN1SMN1; SMN2MCL1
SCHEMBL14355044 0.86 ALDH1A1 (0.45) ALDH1A1KMT2AMEN1SMN1; SMN2MCL1
SCHEMBL5723397 0.86 ALDH1A1 (0.45) ALDH1A1KMT2AMEN1SMN1; SMN2MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1519235-B1 Linked dihydrazone-based charge transport compounds SAMSUNG ELECTRONICS CO LTD (KR) 2007-07-11 EP disclosed
EP-1418469-B1 Organophotoreceptor with charge transport compound with hydrazone groups SAMSUNG ELECTRONICS CO LTD (KR) 2007-04-04 EP disclosed
US-7074532-B2 Linked dihydrazone-based charge transport compounds SAMSUNG ELECTRONICS, CO., LTD. (KR) 2006-07-11 US disclosed
US-7014968-B2 Organophotoreceptor with charge transport material having a thiiranyl group SAMSUNG ELECTRONICS CO., LTD. (KR) 2006-03-21 US disclosed
US-6991882-B2 Organophotoreceptor with charge transport compound with hydrazone groups SAMSUNG ELECTRONICS CO., LTD. (KR) 2006-01-31 US disclosed
US-20050147904-A1 Organophotoreceptor with charge transport material having a thiiranyl group S-PRINTING SOLUTION CO., LTD. (KR) 2005-07-07 US disclosed
EP-1550913-A1 Organophotoreceptor with charge transport material having a thiiranyl group Samsung Electronics Co., Ltd. (KR) 2005-07-06 EP disclosed
EP-1519235-A2 Linked dihydrazone-based charge transport compounds Samsung Electronics Co., Ltd. (KR) 2005-03-30 EP disclosed
US-20050058916-A1 Linked dihydrazone-based charge transport compounds S-PRINTING SOLUTION CO., LTD. (KR) 2005-03-17 US disclosed
US-20040152002-A1 Organophotoreceptor with charge transport material having two linked hydrazone groups SAMSUNG ELECTRONICS CO., LTD. (KR) 2004-08-05 US disclosed
EP-1443039-A1 Organophotoreceptor with charge transport material having two linked hydrazone groups Samsung Electronics Co., Ltd. (KR) 2004-08-04 EP disclosed
US-20040106054-A1 Organophotoreceptor with charge transport compound with hydrazone groups S-PRINTING SOLUTION CO., LTD. (KR) 2004-06-03 US disclosed
EP-1418469-A2 Organophotoreceptor with charge transport compound with hydrazone groups Samsung Electronics Co., Ltd. (KR) 2004-05-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050147904-A1 Organophotoreceptor with charge transport material having a thiiranyl group NR2E3, NR2C2, SLC18A2 ALDH1A1 1608/4885KMT2A 3245/4885MEN1 704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.